New York State Common Retirement Fund Has $5.71 Million Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)

New York State Common Retirement Fund boosted its position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 14.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 246,034 shares of the company's stock after acquiring an additional 31,400 shares during the period. New York State Common Retirement Fund owned approximately 0.14% of Option Care Health worth $5,708,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Creative Planning grew its stake in shares of Option Care Health by 116.7% in the 3rd quarter. Creative Planning now owns 38,149 shares of the company's stock valued at $1,194,000 after purchasing an additional 20,546 shares during the period. Raymond James & Associates grew its stake in shares of Option Care Health by 6.3% in the 3rd quarter. Raymond James & Associates now owns 85,279 shares of the company's stock valued at $2,669,000 after purchasing an additional 5,049 shares during the period. International Assets Investment Management LLC grew its stake in shares of Option Care Health by 3,029.7% in the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company's stock valued at $91,000 after purchasing an additional 2,757 shares during the period. Wealth Enhancement Advisory Services LLC bought a new stake in shares of Option Care Health in the 3rd quarter valued at approximately $206,000. Finally, State of Alaska Department of Revenue grew its stake in shares of Option Care Health by 3.8% in the 3rd quarter. State of Alaska Department of Revenue now owns 19,871 shares of the company's stock valued at $621,000 after purchasing an additional 735 shares during the period. 98.05% of the stock is currently owned by institutional investors.

Remove Ads

Option Care Health Trading Up 1.5 %

NASDAQ:OPCH traded up $0.50 during trading hours on Monday, hitting $34.00. 1,022,471 shares of the stock were exchanged, compared to its average volume of 1,582,553. The company's 50 day moving average is $28.70 and its two-hundred day moving average is $28.06. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $34.54. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The company has a market capitalization of $5.79 billion, a P/E ratio of 28.59, a price-to-earnings-growth ratio of 2.30 and a beta of 1.35.

Wall Street Analyst Weigh In

OPCH has been the topic of several analyst reports. JMP Securities reiterated a "market outperform" rating and issued a $30.00 price objective (down from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Barrington Research upped their price objective on Option Care Health from $33.00 to $38.00 and gave the company an "outperform" rating in a research note on Thursday. The Goldman Sachs Group downgraded Option Care Health from a "buy" rating to a "neutral" rating and reduced their target price for the stock from $38.00 to $27.00 in a report on Monday, November 4th. UBS Group started coverage on Option Care Health in a report on Thursday, December 5th. They issued a "neutral" rating and a $26.00 target price on the stock. Finally, Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and boosted their target price for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $32.88.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.